Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 368
interventional 319
Observational 44
Registry 5

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 107
Drug|Other 23
Biological|Drug|Procedure 21
Biological 20
Biological|Drug|Procedure|Radiation 20
Drug|Procedure 13
Drug|Procedure|Radiation 12
Drug|Other|Procedure|Radiation 11
Procedure 10
Biological|Drug 9
Drug|placebo 9
Drug|Radiation 7
Biological|Drug|Other|Procedure|Radiation 5
Other 5
Biological|Drug|Other 4
Biological|Drug|Radiation 4
Biological|Other 4
Drug|Other|Procedure 4
Biological|Procedure 3
Device 3
Dietary Supplement 3
Biological|Drug|Genetic|Other|Procedure 2
Biological|Drug|Other|Procedure 2
Biological|Other|placebo 2
Dietary Supplement|Drug 2
Other|Procedure 2
Behavioral|Dietary Supplement|Other|Procedure 1
Behavioral|Drug 1
Behavioral|Other 1
Biological|Device|Drug|Procedure|Radiation 1
Biological|Dietary Supplement|Drug|Procedure 1
Biological|Drug|placebo 1
Biological|placebo 1
Diagnostic Test 1
Drug|Genetic|Other|Procedure 1
Drug|Genetic|Other|Procedure|Radiation 1
Drug|Other|placebo|Procedure 1
Drug|placebo|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 249
France 5
NA 5
United States|Canada 4
United States|Italy 4
China 3
Korea, Republic of 3
United Kingdom 3
United States|Australia|Canada 3
United States|Germany|Italy 3
Canada 2
Denmark 2
Italy 2
United States|Denmark|Germany 2
United States|France|United Kingdom 2
Australia|Belgium|Canada|Denmark|France|Germany|Ireland|Italy|Netherlands|Spain|United Kingdom 1
Belgium 1
Brazil 1
Canada|United States|Australia|Netherlands|New Zealand|Puerto Rico|Switzerland 1
Germany 1
Germany|Italy|United Kingdom 1
Japan|Taiwan 1
Japan|United States|Australia|Austria|Belgium|Canada|China|France|Germany|Italy|Netherlands|Poland|Russian Federation|Spain|Sweden|United Kingdom 1
Russian Federation 1
Switzerland 1
United States|Australia 1
United States|Australia|Austria|Canada|France|Germany|Italy|Spain|Sweden 1
United States|Australia|Belgium|Bulgaria|Canada|France|Germany|Greece|Israel|Italy|Lebanon|Malaysia|Netherlands|Spain|Sweden|Taiwan|Thailand|Tunisia|Turkey|United Kingdom 1
United States|Australia|Canada|New Zealand|Puerto Rico|Saudi Arabia 1
United States|Australia|Canada|New Zealand|Saudi Arabia 1
United States|Australia|Canada|Puerto Rico 1
United States|Austria|Canada|France|Germany|Italy|Japan|Spain|Switzerland|United Kingdom 1
United States|Austria|Netherlands 1
United States|Canada|New Zealand 1
United States|Canada|Puerto Rico 1
United States|Denmark 1
United States|France|Hungary|Italy|Japan|Korea, Republic of|Malaysia|Netherlands|Russian Federation|Spain|Thailand|Turkey|United Kingdom 1
United States|France|Italy|Spain 1
United States|France|Italy|United Kingdom 1
United States|Germany 1
United States|Germany|Netherlands 1
United States|Spain|United Kingdom 1

Sites per Study

Site_count Study_Count
1 195
2 30
3 11
4 7
5 9
6 8
7 3
8 3
9 4
10 3
11 7
12 3
13 1
14 2
15 2
16 1
18 1
19 1
21 2
22 1
23 1
24 2
25 2
26 1
30 1
31 1
35 1
36 1
38 1
39 1
43 1
45 1
53 1
59 1
68 1
85 1
87 1
112 1
123 1
165 1
185 1
237 1
326 1

Phase

Phase Study_Count
Phase 2 146
Phase 1 67
Phase 1/Phase 2 39
Phase 3 31
N/A 30
Early Phase 1 4
Phase 2/Phase 3 1
Phase 4 1

Number of Arms

Number_of_Arms Count_of_Studies
1 145
2 55
3 13
4 4
5 1
6 5
9 1
NA 95

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 15.00 5.00 10.00000 17.0000 3.00000 362 20.0000 72
1st Qu. 18.75 19.00 25.00000 31.7500 28.75000 362 92.5000 72
Median 20.00 63.50 40.00000 47.0000 50.00000 362 208.0000 72
Mean 21.25 134.25 40.95918 69.9375 75.10156 362 327.6296 72
3rd Qu. 22.50 106.50 51.00000 55.2500 99.25000 362 326.5000 72
Max. 30.00 1398.00 100.00000 325.0000 455.00000 362 2000.0000 72

Trial Group Type

group_type Group_Count
Experimental 282
NA 95
Active Comparator 39
Other 15
Placebo Comparator 11
No Intervention 5
Sham Comparator 2

Intervention Model

intervention_model Study_Count
Single Group Assignment 169
NA 76
Parallel Assignment 68
Crossover Assignment 4
Factorial Assignment 1
Sequential Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 261
Supportive Care 46
Prevention 3
NA 3
Basic Science 2
Diagnostic 2
Health Services Research 1
Screening 1

Observational Studies

Studies by Country

Country Study_Count
United States 19
France 7
NA 3
Austria 2
United States|Puerto Rico 2
Czechia|Germany|Israel|Italy|Spain|United Kingdom 1
Denmark 1
Denmark|Hungary 1
Italy 1
Italy|Spain|Sweden 1
Spain|United States|Denmark|France|Germany|Italy|United Kingdom 1
Taiwan 1
United States|Australia|Canada|New Zealand|Puerto Rico|Saudi Arabia 1
United States|Canada|France|Germany|Italy|Spain|United Kingdom 1
United States|Canada|Italy|United Kingdom 1
United States|Italy 1

Sites per Study

Site_count Study_Count
1 21
2 6
3 2
6 2
7 2
11 1
18 1
22 1
23 1
30 1
42 1
116 1
228 1
266 1
280 1
292 1

Enrollment Metrics

Measure Observational
Min 8.000
1st Qu 56.250
Median 160.500
Mean 1669.523
3rd Qu 694.000
Max 33000.000

Observation Model

observational_model Study_Count
Cohort 21
NA 8
Case-Only 6
Case Control 3
Other 3
Case-Control 2
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 27
Retrospective 7
NA 6
Other 3
Cross-Sectional 1

Registries

Studies by Country

Country Study_Count
Brazil 1
Canada 1
Italy 1
Taiwan 1
United States 1

Sites per Study

Site_count Study_Count
1 3
7 1
19 1

Enrollment Metrics

Measure Registries
Min 450
1st Qu 500
Median 1000
Mean 1590
3rd Qu 1000
Max 5000

Registry Model

observational_model Study_Count
Case-Only 2
Other 2
Cohort 1

Time Perspective

time_perspective Study_Count
Prospective 4
Other 1

Follow-up

target_duration Study_Count
1 Year 1
10 Years 1
2 Years 1
5 Years 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03912064 A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT https://ClinicalTrials.gov/show/NCT03912064 Recruiting Dana-Farber Cancer Institute 2022-04-26
NCT03397173 TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid https://ClinicalTrials.gov/show/NCT03397173 Recruiting Case Comprehensive Cancer Center 2020-10-31
NCT03333486 Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer https://ClinicalTrials.gov/show/NCT03333486 Recruiting Roswell Park Cancer Institute 2022-09-06
NCT03314974 Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders https://ClinicalTrials.gov/show/NCT03314974 Recruiting Masonic Cancer Center, University of Minnesota 2025-01-10
NCT03289910 Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia https://ClinicalTrials.gov/show/NCT03289910 Recruiting National Cancer Institute (NCI) 2021-06-01
NCT03238248 Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors https://ClinicalTrials.gov/show/NCT03238248 Recruiting Vanderbilt-Ingram Cancer Center 2022-07-31
NCT03194542 A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence https://ClinicalTrials.gov/show/NCT03194542 Recruiting Celgene 2021-06-16
NCT03149055 Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT) https://ClinicalTrials.gov/show/NCT03149055 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-05-31
NCT03144687 A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis https://ClinicalTrials.gov/show/NCT03144687 Active, not recruiting Incyte Corporation 2020-07-31
NCT03140280 Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) https://ClinicalTrials.gov/show/NCT03140280 Active, not recruiting Medical College of Wisconsin 2019-06-01
NCT03128359 High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT03128359 Recruiting City of Hope Medical Center 2021-01-31
NCT03123588 Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272) https://ClinicalTrials.gov/show/NCT03123588 Recruiting Incyte Corporation 2020-05-31
NCT03075826 A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT03075826 Active, not recruiting Weill Medical College of Cornell University 2021-02-19
NCT03072043 Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms https://ClinicalTrials.gov/show/NCT03072043 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2020-06-30
NCT03065400 PD-1 Inhibition in Advanced Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT03065400 Completed Icahn School of Medicine at Mount Sinai 2020-05-28
NCT03011372 A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203) https://ClinicalTrials.gov/show/NCT03011372 Recruiting Incyte Corporation 2020-07-31
NCT02960646 Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT02960646 Recruiting M.D. Anderson Cancer Center 2020-11-30
NCT02121418 Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm https://ClinicalTrials.gov/show/NCT02121418 Completed University of Washington 2017-02-08
NCT02861417 Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT02861417 Recruiting M.D. Anderson Cancer Center 2021-08-31
NCT02806375 PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis https://ClinicalTrials.gov/show/NCT02806375 Completed St. Petersburg State Pavlov Medical University 2018-12-31
NCT02728050 Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib Tosylate in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT02728050 Recruiting University of Washington 2020-10-31
NCT02727803 Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelodysplastic Syndrome, Leukemia, Lymphoma or Multiple Myeloma https://ClinicalTrials.gov/show/NCT02727803 Recruiting M.D. Anderson Cancer Center 2020-05-19
NCT02722668 UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep https://ClinicalTrials.gov/show/NCT02722668 Recruiting Masonic Cancer Center, University of Minnesota 2028-05-31
NCT02718300 A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis https://ClinicalTrials.gov/show/NCT02718300 Recruiting Incyte Corporation 2021-01-31
NCT02666950 WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT02666950 Completed Mayo Clinic 2018-09-25
NCT02639559 Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies https://ClinicalTrials.gov/show/NCT02639559 Active, not recruiting Washington University School of Medicine 2018-04-12
NCT02257138 Ruxolitinib Phosphate and Decitabine in Treating Patients With Relapsed or Refractory or Post Myeloproliferative Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT02257138 Active, not recruiting M.D. Anderson Cancer Center 2021-02-28
NCT02566304 Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT02566304 Recruiting Thomas Jefferson University 2020-07-23
NCT02556931 Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies https://ClinicalTrials.gov/show/NCT02556931 Active, not recruiting Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2021-07-31
NCT02521493 Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome https://ClinicalTrials.gov/show/NCT02521493 Recruiting Children’s Oncology Group 2023-03-31
NCT02506933 Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant https://ClinicalTrials.gov/show/NCT02506933 Active, not recruiting City of Hope Medical Center 2018-10-31
NCT02424968 CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma https://ClinicalTrials.gov/show/NCT02424968 Active, not recruiting Stanford University 2020-07-31
NCT02396134 Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT02396134 Recruiting City of Hope Medical Center 2020-05-31
NCT02393248 Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) https://ClinicalTrials.gov/show/NCT02393248 Recruiting Incyte Corporation 2020-07-31
NCT03386513 Study of IMGN632 in Patients With Relapse/Refractory AML, BPDCN, ALL, Other CD123+ Hem Malignancies https://ClinicalTrials.gov/show/NCT03386513 Recruiting ImmunoGen, Inc. 2020-08-31
NCT02320656 Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015 https://ClinicalTrials.gov/show/NCT02320656 Recruiting Institut Paoli-Calmettes 2019-05-31
NCT02311569 Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation https://ClinicalTrials.gov/show/NCT02311569 Completed Swiss Group for Clinical Cancer Research 2016-12-31
NCT02267278 Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF) https://ClinicalTrials.gov/show/NCT02267278 Completed M.D. Anderson Cancer Center 2018-06-01
NCT02210858 Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT02210858 Completed National Cancer Institute (NCI) 2004-11-12
NCT02158858 A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis https://ClinicalTrials.gov/show/NCT02158858 Recruiting Constellation Pharmaceuticals 2021-08-31
NCT02129101 Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies https://ClinicalTrials.gov/show/NCT02129101 Completed Mayo Clinic 2016-12-31
NCT02125318 A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders https://ClinicalTrials.gov/show/NCT02125318 Completed Galena Biopharma, Inc. 2016-05-31
NCT02084563 Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms https://ClinicalTrials.gov/show/NCT02084563 Completed Hospital Israelita Albert Einstein 2014-12-31
NCT02076191 Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML https://ClinicalTrials.gov/show/NCT02076191 Completed Icahn School of Medicine at Mount Sinai 2018-07-20
NCT01305200 Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01305200 Completed Children’s Oncology Group 2015-06-30
NCT01273766 Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01273766 Completed Wake Forest University Health Sciences 2012-03-31
NCT02029950 Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT02029950 Active, not recruiting National Cancer Institute (NCI) 2020-07-04
NCT01894477 Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01894477 Active, not recruiting Fred Hutchinson Cancer Research Center 2017-01-09
NCT01872819 Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay https://ClinicalTrials.gov/show/NCT01872819 Completed University of Washington 2014-11-30
NCT01866839 Preventing Stem Cell Transplant Complications With a Blood Separator Machine https://ClinicalTrials.gov/show/NCT01866839 Completed National Institutes of Health Clinical Center (CC) 2018-05-23
NCT01844765 Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. https://ClinicalTrials.gov/show/NCT01844765 Active, not recruiting Novartis 2016-06-01
NCT01831232 Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT01831232 Completed Fred Hutchinson Cancer Research Center 2015-02-28
NCT01816256 Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT01816256 Completed University Health Network, Toronto 2019-03-11
NCT01789255 Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies https://ClinicalTrials.gov/show/NCT01789255 Completed National Cancer Institute (NCI) 2014-03-31
NCT01787552 A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF https://ClinicalTrials.gov/show/NCT01787552 Completed Novartis 2018-04-10
NCT01761968 Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT01761968 Active, not recruiting Italfarmaco 2022-06-30
NCT01758042 Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders https://ClinicalTrials.gov/show/NCT01758042 Recruiting Massachusetts General Hospital 2019-07-31
NCT01712308 Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia https://ClinicalTrials.gov/show/NCT01712308 Recruiting M.D. Anderson Cancer Center 2020-02-28
NCT01684150 A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving https://ClinicalTrials.gov/show/NCT01684150 Completed Epizyme, Inc. 2015-11-30
NCT01633372 An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis https://ClinicalTrials.gov/show/NCT01633372 Active, not recruiting Incyte Corporation 2013-12-31
NCT01594723 A Study of LY2784544 in Participants With Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT01594723 Active, not recruiting Eli Lilly and Company 2015-03-20
NCT01572662 Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning https://ClinicalTrials.gov/show/NCT01572662 Active, not recruiting M.D. Anderson Cancer Center 2020-04-30
NCT01529827 Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01529827 Completed Roswell Park Cancer Institute 2015-05-28
NCT01527045 Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies https://ClinicalTrials.gov/show/NCT01527045 Completed Fred Hutchinson Cancer Research Center 2018-10-31
NCT01520220 Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT01520220 Completed Eli Lilly and Company 2015-06-26
NCT01499147 Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01499147 Completed University of Illinois at Chicago 2013-05-31
NCT01484015 Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia https://ClinicalTrials.gov/show/NCT01484015 Completed Wake Forest University Health Sciences 2012-06-30
NCT01444742 Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS) https://ClinicalTrials.gov/show/NCT01444742 Completed M.D. Anderson Cancer Center 2017-01-29
NCT01413568 Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01413568 Completed Polyphor Ltd. 2015-11-30
NCT01393509 The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies https://ClinicalTrials.gov/show/NCT01393509 Active, not recruiting Memorial Sloan Kettering Cancer Center 2020-07-31
NCT01392989 Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT01392989 Completed Stanford University 2016-06-07
NCT01384513 A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies https://ClinicalTrials.gov/show/NCT01384513 Recruiting Thomas Jefferson University 2020-12-31
NCT01375140 Ruxolitinib and Lenalidomide for Patients With Myelofibrosis https://ClinicalTrials.gov/show/NCT01375140 Completed M.D. Anderson Cancer Center 2018-09-05
NCT01366612 PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation https://ClinicalTrials.gov/show/NCT01366612 Active, not recruiting Hackensack Meridian Health 2022-08-31
NCT01348490 Ruxolitinib (INCB018424) in Participants With Primary Myelofibrosis (PMF), Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosis (PPV-MF) https://ClinicalTrials.gov/show/NCT01348490 Completed Incyte Corporation 2018-12-19
NCT03878524 Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial https://ClinicalTrials.gov/show/NCT03878524 Recruiting OHSU Knight Cancer Institute 2022-02-27
NCT04339400 A Study of TQ05105 Tablets in Subjects With Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT04339400 Recruiting Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 2020-12-31
NCT04282187 Decitabine With Ruxolitinib or Fedratinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT04282187 Recruiting University of Washington 2024-11-11
NCT04191187 Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT04191187 Recruiting H. Lee Moffitt Cancer Center and Research Institute 2022-12-31
NCT04156256 CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies https://ClinicalTrials.gov/show/NCT04156256 Recruiting iCell Gene Therapeutics 2020-09-30
NCT04113616 An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML) https://ClinicalTrials.gov/show/NCT04113616 Recruiting Kartos Therapeutics, Inc. 2023-12-15
NCT04064060 A Study to Evaluate Long-term Safety in Subjects Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials https://ClinicalTrials.gov/show/NCT04064060 Recruiting Celgene 2028-01-24
NCT04060277 Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT04060277 Recruiting City of Hope Medical Center 2022-07-22
NCT04051307 Dual Vaccine Trial in Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT04051307 Recruiting Herlev Hospital 2022-07-10
NCT04022785 PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT04022785 Recruiting M.D. Anderson Cancer Center 2022-12-31
NCT03977103 Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT https://ClinicalTrials.gov/show/NCT03977103 Recruiting University Of Perugia 2023-02-28
NCT03907436 The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase https://ClinicalTrials.gov/show/NCT03907436 Completed University of California, Irvine 2019-10-01
NCT03878199 Ruxolitinib and Daunorubicin (CPX-351) in Treating Patients With Secondary Acute Myeloid Leukemia Transformed From Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT03878199 Recruiting OHSU Knight Cancer Institute 2021-12-31
NCT03869476 Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms. https://ClinicalTrials.gov/show/NCT03869476 Recruiting University Hospital, Angers 2023-06-30
NCT03862157 Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT03862157 Recruiting M.D. Anderson Cancer Center 2024-01-01
NCT03808805 Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT03808805 Recruiting University Hospital, Brest 2020-09-01
NCT03795779 CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies https://ClinicalTrials.gov/show/NCT03795779 Recruiting iCell Gene Therapeutics 2020-09-30
NCT03734601 Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation https://ClinicalTrials.gov/show/NCT03734601 Active, not recruiting Stanford University 2020-11-30
NCT03726944 The Feasibility of Delivering Consumer-based Meditation Applications to Myeloproliferative Neoplasm Patients https://ClinicalTrials.gov/show/NCT03726944 Completed Arizona State University 2018-04-02
NCT03630991 Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy https://ClinicalTrials.gov/show/NCT03630991 Active, not recruiting M.D. Anderson Cancer Center 2020-12-31
NCT03622788 Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant https://ClinicalTrials.gov/show/NCT03622788 Recruiting M.D. Anderson Cancer Center 2021-07-01
NCT03613532 Venetoclax Added to Fludarabine + Busulfan Prior to Transplant for AML, MDS, and MDS/MPN https://ClinicalTrials.gov/show/NCT03613532 Recruiting Dana-Farber Cancer Institute 2020-10-01
NCT03589729 Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers https://ClinicalTrials.gov/show/NCT03589729 Recruiting M.D. Anderson Cancer Center 2020-12-31
NCT03588078 Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine https://ClinicalTrials.gov/show/NCT03588078 Active, not recruiting Groupe Francophone des Myelodysplasies 2020-05-01
NCT03566446 CALR Exon 9 Mutant Peptide Vaccine to Patients With CALR-mutant Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT03566446 Active, not recruiting Herlev Hospital 2020-02-20
NCT03560752 CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Blood Cancer Undergoing Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT03560752 Recruiting City of Hope Medical Center 2021-03-18
NCT03558607 The Role of Ruxolitinib in Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Neoplasm https://ClinicalTrials.gov/show/NCT03558607 Recruiting Seoul National University Hospital 2022-04-30
NCT03519984 EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia https://ClinicalTrials.gov/show/NCT03519984 Recruiting University of Southern California 2020-05-09
NCT03480360 Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators’ Expression https://ClinicalTrials.gov/show/NCT03480360 Recruiting Dartmouth-Hitchcock Medical Center 2021-12-31
NCT03471260 Ivosidenib and Venetoclax With or Without Azacitidine in Treating Participants With IDH1 Mutated Hematologic Malignancies https://ClinicalTrials.gov/show/NCT03471260 Recruiting M.D. Anderson Cancer Center 2021-09-30
NCT03434730 Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation https://ClinicalTrials.gov/show/NCT03434730 Recruiting Memorial Sloan Kettering Cancer Center 2021-02-07
NCT01233921 Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT01233921 Completed Fred Hutchinson Cancer Research Center 2012-07-31
NCT01231919 MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia https://ClinicalTrials.gov/show/NCT01231919 Completed National Cancer Institute (NCI) 2013-04-30
NCT01231412 Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01231412 Completed Fred Hutchinson Cancer Research Center 2016-10-08
NCT01200498 Study of SB939 in Subjects With Myelofibrosis https://ClinicalTrials.gov/show/NCT01200498 Completed M.D. Anderson Cancer Center 2012-11-30
NCT01178281 Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence https://ClinicalTrials.gov/show/NCT01178281 Completed Celgene 2013-01-01
NCT01167166 Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL) https://ClinicalTrials.gov/show/NCT01167166 Completed Onconova Therapeutics, Inc. 2013-12-31
NCT01164163 INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease https://ClinicalTrials.gov/show/NCT01164163 Completed Children’s Oncology Group 2014-10-31
NCT01134120 A Study in Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT01134120 Completed Eli Lilly and Company 2014-04-30
NCT01101880 Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm https://ClinicalTrials.gov/show/NCT01101880 Completed University of Washington 2013-06-30
NCT01093586 Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01093586 Completed Case Comprehensive Cancer Center 2015-12-31
NCT01056614 Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies https://ClinicalTrials.gov/show/NCT01056614 Completed Fred Hutchinson Cancer Research Center 2005-08-31
NCT01045382 MSC and HSC Coinfusion in Mismatched Minitransplants https://ClinicalTrials.gov/show/NCT01045382 Recruiting University of Liege 2021-07-31
NCT00988715 Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00988715 Completed Fred Hutchinson Cancer Research Center 2015-01-31
NCT00952289 COntrolled MyeloFibrosis Study With ORal JAK Inhibitor Treatment: The COMFORT-I Trial https://ClinicalTrials.gov/show/NCT00952289 Completed Incyte Corporation 2010-11-30
NCT00951626 A Standardized Nursing Intervention Protocol for HCT Patients https://ClinicalTrials.gov/show/NCT00951626 Completed City of Hope Medical Center 2011-09-30
NCT00949364 Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage https://ClinicalTrials.gov/show/NCT00949364 Completed University of Ulm 2016-12-14
NCT00935090 3’-Deoxy-3’-[18F] Fluorothymidine PET Imaging in Patients With Cancer https://ClinicalTrials.gov/show/NCT00935090 Recruiting Barbara Ann Karmanos Cancer Institute 2021-04-30
NCT00908167 Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies https://ClinicalTrials.gov/show/NCT00908167 Completed St. Jude Children’s Research Hospital 2015-06-30
NCT00890747 Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT00890747 Completed National Cancer Institute (NCI) 2011-05-31
NCT00858572 STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00858572 Completed Synta Pharmaceuticals Corp. 2011-05-31
NCT00856388 Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders https://ClinicalTrials.gov/show/NCT00856388 Completed Roswell Park Cancer Institute 2012-08-09
NCT00823524 Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT00823524 Completed Asan Medical Center 2013-02-28
NCT03192397 Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT03192397 Recruiting Roswell Park Cancer Institute 2021-07-01
NCT01951885 Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention https://ClinicalTrials.gov/show/NCT01951885 Recruiting Case Comprehensive Cancer Center 2020-07-31
NCT01787487 Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm https://ClinicalTrials.gov/show/NCT01787487 Recruiting M.D. Anderson Cancer Center 2020-07-26
NCT00806767 Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer https://ClinicalTrials.gov/show/NCT00806767 Completed National Cancer Institute (NCI) 2011-05-31
NCT01822509 Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01822509 Active, not recruiting National Cancer Institute (NCI) 2018-12-31
NCT00003838 Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow https://ClinicalTrials.gov/show/NCT00003838 Completed National Institutes of Health Clinical Center (CC) 2018-12-14
NCT04103645 Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN Patients https://ClinicalTrials.gov/show/NCT04103645 Active, not recruiting Weill Medical College of Cornell University 2022-09-30
NCT04041050 A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Alone and in Combination With Ruxolitinib in Asian Adult Participants With Myeloproliferative Neoplasm https://ClinicalTrials.gov/show/NCT04041050 Recruiting AbbVie 2022-07-31
NCT03246906 Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation https://ClinicalTrials.gov/show/NCT03246906 Recruiting Fred Hutchinson Cancer Research Center 2022-08-15
NCT00787761 Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer https://ClinicalTrials.gov/show/NCT00787761 Completed Northside Hospital, Inc. 2010-07-31
NCT00782145 A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families https://ClinicalTrials.gov/show/NCT00782145 Completed Tufts Medical Center 2011-06-30
NCT00755040 Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder https://ClinicalTrials.gov/show/NCT00755040 Completed Vanderbilt-Ingram Cancer Center 2014-12-31
NCT00750009 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial https://ClinicalTrials.gov/show/NCT00750009 Completed Case Comprehensive Cancer Center 2012-12-31
NCT00745550 A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis https://ClinicalTrials.gov/show/NCT00745550 Completed S*BIO 2012-01-31
NCT00723099 Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00723099 Completed Fred Hutchinson Cancer Research Center 2018-07-31
NCT00719563 American Ginseng in Treating Patients With Fatigue Caused by Cancer https://ClinicalTrials.gov/show/NCT00719563 Completed Alliance for Clinical Trials in Oncology 2011-08-31
NCT00716911 Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00716911 Completed City of Hope Medical Center 2007-07-31
NCT00691015 Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00691015 Completed Barbara Ann Karmanos Cancer Institute 2014-04-30
NCT00683046 T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT00683046 Completed University of Chicago 2014-12-31
NCT00669578 CC-4047 in Treating Patients With Myelofibrosis https://ClinicalTrials.gov/show/NCT00669578 Completed Mayo Clinic 2010-07-07
NCT00666211 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain https://ClinicalTrials.gov/show/NCT00666211 Completed Vanderbilt-Ingram Cancer Center 2010-01-31
NCT00636909 Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders https://ClinicalTrials.gov/show/NCT00636909 Completed Beth Israel Deaconess Medical Center 2006-03-31
NCT00627666 Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer https://ClinicalTrials.gov/show/NCT00627666 Completed National Cancer Institute (NCI) 2010-06-30
NCT00624936 Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00624936 Completed Ohio State University Comprehensive Cancer Center 2009-12-31
NCT00611351 Busulfan, Cyclophosphamide, and Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00611351 Completed University of Nebraska 2008-02-29
NCT00606307 Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases https://ClinicalTrials.gov/show/NCT00606307 Completed Italfarmaco 2008-12-31
NCT00592046 A Phase I Trial of ZIO-101 in Hematologic Cancers https://ClinicalTrials.gov/show/NCT00592046 Completed Ziopharm 2008-06-30
NCT00589563 Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer https://ClinicalTrials.gov/show/NCT00589563 Completed City of Hope Medical Center 2012-02-29
NCT00588991 Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00588991 Active, not recruiting National Cancer Institute (NCI) 2014-02-01
NCT00588809 Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00588809 Completed National Cancer Institute (NCI) 2012-04-30
NCT00588666 Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma https://ClinicalTrials.gov/show/NCT00588666 Completed Memorial Sloan Kettering Cancer Center 2011-12-31
NCT00544115 Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders https://ClinicalTrials.gov/show/NCT00544115 Active, not recruiting City of Hope Medical Center 2019-11-30
NCT00539695 Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD https://ClinicalTrials.gov/show/NCT00539695 Completed Baylor College of Medicine 2013-04-30
NCT00533923 Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders https://ClinicalTrials.gov/show/NCT00533923 Completed Beth Israel Deaconess Medical Center 2007-01-31
NCT00530218 Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant https://ClinicalTrials.gov/show/NCT00530218 Completed City of Hope Medical Center 2010-02-28
NCT00516503 Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer https://ClinicalTrials.gov/show/NCT00516503 Completed Alliance for Clinical Trials in Oncology 2009-04-30
NCT00516152 Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT https://ClinicalTrials.gov/show/NCT00516152 Completed University of California, San Francisco NA
NCT00513474 Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00513474 Completed Massachusetts General Hospital 2013-02-12
NCT00489203 Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00489203 Completed Fred Hutchinson Cancer Research Center 2010-11-30
NCT00462605 MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT00462605 Completed National Cancer Institute (NCI) 2011-03-31
NCT00453206 Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases https://ClinicalTrials.gov/show/NCT00453206 Completed Wake Forest University Health Sciences 2014-02-28
NCT00452023 Pegasys® in Patients With Myeloproliferative Diseases https://ClinicalTrials.gov/show/NCT00452023 Active, not recruiting M.D. Anderson Cancer Center 2020-12-31
NCT00448357 Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen https://ClinicalTrials.gov/show/NCT00448357 Completed UNC Lineberger Comprehensive Cancer Center 2015-11-30
NCT00448201 Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease https://ClinicalTrials.gov/show/NCT00448201 Completed UNC Lineberger Comprehensive Cancer Center 2011-01-11
NCT00445900 Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia https://ClinicalTrials.gov/show/NCT00445900 Completed Mayo Clinic 2006-10-31
NCT00438958 Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases https://ClinicalTrials.gov/show/NCT00438958 Completed National Cancer Institute (NCI) NA
NCT00437086 Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00437086 Completed Mayo Clinic 2008-11-30
NCT00425477 Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00425477 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2016-09-30
NCT00424242 Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases https://ClinicalTrials.gov/show/NCT00424242 Active, not recruiting Northwestern University 2020-03-31
NCT00410657 Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00410657 Completed Fred Hutchinson Cancer Research Center 2006-11-30
NCT00408681 Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00408681 Completed Fred Hutchinson Cancer Research Center 2010-11-30
NCT00397813 Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00397813 Completed Fred Hutchinson Cancer Research Center 2017-09-30
NCT00799461 Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications https://ClinicalTrials.gov/show/NCT00799461 Completed Fred Hutchinson Cancer Research Center 2011-11-30
NCT00381550 3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia https://ClinicalTrials.gov/show/NCT00381550 Completed National Cancer Institute (NCI) 2011-03-31
NCT00376922 Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases https://ClinicalTrials.gov/show/NCT00376922 Completed Wake Forest University Health Sciences 2007-05-31
NCT00361140 Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) https://ClinicalTrials.gov/show/NCT00361140 Completed H. Lee Moffitt Cancer Center and Research Institute 2012-02-29
NCT00357708 Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases https://ClinicalTrials.gov/show/NCT00357708 Completed National Cancer Institute (NCI) 2009-10-31
NCT00357305 Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00357305 Completed National Cancer Institute (NCI) 2011-11-30
NCT00351975 Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases https://ClinicalTrials.gov/show/NCT00351975 Completed National Cancer Institute (NCI) 2013-03-31
NCT00346359 Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer https://ClinicalTrials.gov/show/NCT00346359 Completed Fred Hutchinson Cancer Research Center NA
NCT00331513 Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00331513 Completed National Cancer Institute (NCI) 2010-01-31
NCT00322101 Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia https://ClinicalTrials.gov/show/NCT00322101 Completed Fred Hutchinson Cancer Research Center 2012-04-30
NCT00305682 Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant https://ClinicalTrials.gov/show/NCT00305682 Active, not recruiting Masonic Cancer Center, University of Minnesota 2020-06-30
NCT00301938 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00301938 Completed National Cancer Institute (NCI) 2012-05-31
NCT00296023 Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00296023 Completed University of California, San Francisco 2007-06-30
NCT00293410 Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00293410 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2010-04-30
NCT00293384 Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00293384 Completed Barbara Ann Karmanos Cancer Institute 2009-06-30
NCT00290641 Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00290641 Completed Masonic Cancer Center, University of Minnesota 2006-01-31
NCT00283114 A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00283114 Completed Seattle Genetics, Inc. 2010-01-31
NCT00274820 Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder https://ClinicalTrials.gov/show/NCT00274820 Completed Case Comprehensive Cancer Center 2007-09-30
NCT00265837 Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00265837 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2007-08-31
NCT00255710 Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00255710 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins NA
NCT00245037 Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00245037 Completed OHSU Knight Cancer Institute 2015-08-31
NCT00217386 Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00217386 Completed Fred Hutchinson Cancer Research Center 2007-12-31
NCT00186576 Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00186576 Completed Stanford University 2004-03-31
NCT00186342 Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies https://ClinicalTrials.gov/show/NCT00186342 Completed Stanford University 2009-01-31
NCT00185796 TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD https://ClinicalTrials.gov/show/NCT00185796 Completed Stanford University 2014-04-30
NCT00175838 Primary Thrombocythaemia 1 Trial https://ClinicalTrials.gov/show/NCT00175838 Completed University of Cambridge 2016-11-30
NCT00146055 Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood https://ClinicalTrials.gov/show/NCT00146055 Completed University of Michigan Rogel Cancer Center 2004-11-30
NCT00134017 Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00134017 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2010-02-28
NCT00134004 Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00134004 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2015-01-31
NCT00132015 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis https://ClinicalTrials.gov/show/NCT00132015 Completed National Institutes of Health Clinical Center (CC) 2007-12-31
NCT00118352 Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00118352 Completed Fred Hutchinson Cancer Research Center 2010-07-31
NCT00114257 Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00114257 Completed National Cancer Institute (NCI) 2006-09-30
NCT00112593 Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer https://ClinicalTrials.gov/show/NCT00112593 Completed Fred Hutchinson Cancer Research Center 2014-11-30
NCT00109993 Campath-1H + FK506 and Methylprednisolone for GVHD https://ClinicalTrials.gov/show/NCT00109993 Completed Case Comprehensive Cancer Center 2006-06-30
NCT00105001 Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00105001 Completed Fred Hutchinson Cancer Research Center 2011-05-31
NCT00104975 Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00104975 Completed Yale University 2008-05-31
NCT00104923 Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer https://ClinicalTrials.gov/show/NCT00104923 Completed California Cancer Consortium 2017-04-30
NCT00098683 Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00098683 Completed Children’s Oncology Group 2007-10-31
NCT00096161 Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00096161 Completed Fred Hutchinson Cancer Research Center 2015-02-28
NCT00096096 Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00096096 Completed Fred Hutchinson Cancer Research Center 2006-05-31
NCT00093366 Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00093366 Completed Fred Hutchinson Cancer Research Center NA
NCT00003451 Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT00003451 Completed National Cancer Institute (NCI) 2001-12-31
NCT00003331 Combination Chemotherapy in Treating Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT00003331 Completed NYU Langone Health 2001-11-30
NCT00002980 Decitabine in Treating Patients With Melanoma or Other Advanced Cancer https://ClinicalTrials.gov/show/NCT00002980 Completed National Cancer Institute (NCI) NA
NCT00003406 Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer https://ClinicalTrials.gov/show/NCT00003406 Completed National Cancer Institute (NCI) NA
NCT00002742 Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00002742 Completed National Cancer Institute (NCI) NA
NCT00089037 Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00089037 Completed Fred Hutchinson Cancer Research Center 2005-04-30
NCT00005805 St. John’s Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer https://ClinicalTrials.gov/show/NCT00005805 Completed Memorial Sloan Kettering Cancer Center 2000-06-30
NCT00004258 EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer https://ClinicalTrials.gov/show/NCT00004258 Completed Indiana University 2001-08-31
NCT00002504 Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer https://ClinicalTrials.gov/show/NCT00002504 Completed Hoag Memorial Hospital Presbyterian 1998-02-28
NCT00003082 Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT00003082 Completed University of Arizona 2001-02-28
NCT00006251 Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer https://ClinicalTrials.gov/show/NCT00006251 Completed Fred Hutchinson Cancer Research Center 2005-09-30
NCT00006083 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter https://ClinicalTrials.gov/show/NCT00006083 Completed Jonsson Comprehensive Cancer Center 2000-11-30
NCT00082654 Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients https://ClinicalTrials.gov/show/NCT00082654 Completed Fred Hutchinson Cancer Research Center 2004-10-31
NCT00083187 VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia https://ClinicalTrials.gov/show/NCT00083187 Completed National Cancer Institute (NCI) 2007-01-31
NCT00003887 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00003887 Completed Fred Hutchinson Cancer Research Center NA
NCT00003619 Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT00003619 Completed National Cancer Institute (NCI) NA
NCT00010283 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon https://ClinicalTrials.gov/show/NCT00010283 Completed Fred Hutchinson Cancer Research Center 2002-07-31
NCT00080925 T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT00080925 Completed National Institutes of Health Clinical Center (CC) NA
NCT00003107 Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors https://ClinicalTrials.gov/show/NCT00003107 Completed Indiana University NA
NCT00006348 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment https://ClinicalTrials.gov/show/NCT00006348 Completed Alliance for Clinical Trials in Oncology 2001-09-30
NCT00078858 Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00078858 Completed Fred Hutchinson Cancer Research Center 2006-01-31
NCT00004904 Stem Cell Transplantation in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00004904 Completed Northwestern University 2000-07-31
NCT00003600 Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT00003600 Completed Alliance for Clinical Trials in Oncology 2001-12-31
NCT00077558 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00077558 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins NA
NCT00075816 Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) https://ClinicalTrials.gov/show/NCT00075816 Completed Medical College of Wisconsin 2013-04-30
NCT00075478 Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00075478 Completed Fred Hutchinson Cancer Research Center 2014-02-28
NCT00006367 Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis https://ClinicalTrials.gov/show/NCT00006367 Completed Fred Hutchinson Cancer Research Center NA
NCT00072475 Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00072475 Completed Alliance for Clinical Trials in Oncology 2008-11-30
NCT00068523 Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT00068523 Completed Case Comprehensive Cancer Center 2004-03-31
NCT00068276 Cholecalciferol in Treating Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00068276 Completed Wake Forest University Health Sciences 2005-06-30
NCT00005804 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00005804 Completed Fred Hutchinson Cancer Research Center 2002-08-31
NCT00066599 Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy https://ClinicalTrials.gov/show/NCT00066599 Completed National Cancer Institute (NCI) NA
NCT00066248 Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment https://ClinicalTrials.gov/show/NCT00066248 Completed University of South Florida 2007-08-31
NCT00064311 Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00064311 Completed National Institutes of Health Clinical Center (CC) NA
NCT00003913 Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease https://ClinicalTrials.gov/show/NCT00003913 Completed Fred Hutchinson Cancer Research Center 2005-08-31
NCT00064090 3-AP and Cytarabine in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00064090 Completed National Cancer Institute (NCI) 2004-09-30
NCT00042900 Pyroxamide in Treating Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT00042900 Completed Memorial Sloan Kettering Cancer Center 2002-09-30
NCT00062140 Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00062140 Completed Fred Hutchinson Cancer Research Center NA
NCT00061581 Experimental Bone Marrow Transplant Protocol https://ClinicalTrials.gov/show/NCT00061581 Completed National Institutes of Health Clinical Center (CC) 2007-12-28
NCT00003408 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer https://ClinicalTrials.gov/show/NCT00003408 Completed National Cancer Institute (NCI) NA
NCT00004232 Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00004232 Completed Northwestern University 2002-10-31
NCT00006225 Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer https://ClinicalTrials.gov/show/NCT00006225 Completed Northwestern University 2004-01-31
NCT00055653 Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders https://ClinicalTrials.gov/show/NCT00055653 Completed Roswell Park Cancer Institute 2003-09-30
NCT00054340 Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder https://ClinicalTrials.gov/show/NCT00054340 Completed Fred Hutchinson Cancer Research Center NA
NCT00054327 Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00054327 Completed Case Comprehensive Cancer Center 2011-09-30
NCT00054236 Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia https://ClinicalTrials.gov/show/NCT00054236 Completed Case Comprehensive Cancer Center 2011-03-31
NCT00053989 NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders https://ClinicalTrials.gov/show/NCT00053989 Completed Roswell Park Cancer Institute 2018-07-19
NCT00053287 Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS https://ClinicalTrials.gov/show/NCT00053287 Completed Case Comprehensive Cancer Center 2007-01-31
NCT00053196 Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer https://ClinicalTrials.gov/show/NCT00053196 Completed Alliance for Clinical Trials in Oncology 2006-11-30
NCT00053157 Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia https://ClinicalTrials.gov/show/NCT00053157 Completed Roswell Park Cancer Institute 2004-08-31
NCT00053001 Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00053001 Completed National Cancer Institute (NCI) NA
NCT00052832 Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia https://ClinicalTrials.gov/show/NCT00052832 Completed University of Wisconsin, Madison 2005-07-31
NCT00049686 VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00049686 Completed National Cancer Institute (NCI) NA
NCT00049634 Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder https://ClinicalTrials.gov/show/NCT00049634 Completed Fred Hutchinson Cancer Research Center 2007-02-28
NCT00045305 Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00045305 Completed Eastern Cooperative Oncology Group 2014-02-28
NCT00044954 Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00044954 Completed University of Texas Southwestern Medical Center 2006-11-30
NCT00042822 FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00042822 Completed National Cancer Institute (NCI) 2005-03-31
NCT00040846 Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies https://ClinicalTrials.gov/show/NCT00040846 Completed Fred Hutchinson Cancer Research Center 2009-12-31
NCT00036790 Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT00036790 Completed University of Wisconsin, Madison 2005-10-31
NCT00030550 Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00030550 Completed Roswell Park Cancer Institute 2003-06-30
NCT00028730 Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00028730 Completed Memorial Sloan Kettering Cancer Center 2006-07-31
NCT00027560 Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00027560 Completed Memorial Sloan Kettering Cancer Center 2009-04-30
NCT00025415 Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction https://ClinicalTrials.gov/show/NCT00025415 Completed National Cancer Institute (NCI) 2005-01-31
NCT00022048 Bevacizumab in Treating Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00022048 Completed National Cancer Institute (NCI) NA
NCT00019656 Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer https://ClinicalTrials.gov/show/NCT00019656 Completed National Cancer Institute (NCI) NA
NCT00795769 Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00795769 Completed Fred Hutchinson Cancer Research Center 2009-06-09
NCT00015925 MS-275 in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00015925 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins NA
NCT00014495 Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer https://ClinicalTrials.gov/show/NCT00014495 Completed Memorial Sloan Kettering Cancer Center 2009-12-31
NCT00014482 Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00014482 Completed Memorial Sloan Kettering Cancer Center 2003-03-31
NCT00014469 Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer https://ClinicalTrials.gov/show/NCT00014469 Completed Memorial Sloan Kettering Cancer Center 2007-05-31
NCT00014235 Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT00014235 Completed Fred Hutchinson Cancer Research Center 2005-02-28
NCT00006379 Non-Ablative Allo HSCT For Hematologic Malignancies or SAA https://ClinicalTrials.gov/show/NCT00006379 Completed Case Comprehensive Cancer Center 2004-01-31
NCT00006239 Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00006239 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2005-02-28
NCT00006042 Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00006042 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins NA
NCT00006040 Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia https://ClinicalTrials.gov/show/NCT00006040 Completed Memorial Sloan Kettering Cancer Center 2003-11-30
NCT00005967 Tipifarnib in Treating Patients With Advanced Hematologic Cancer https://ClinicalTrials.gov/show/NCT00005967 Completed National Cancer Institute (NCI) 2004-04-30
NCT00005863 Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00005863 Completed National Cancer Institute (NCI) NA
NCT00005823 Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00005823 Completed National Cancer Institute (NCI) NA
NCT00005797 Bone Marrow Transplant in Treating Patients With Hematologic Cancers https://ClinicalTrials.gov/show/NCT00005797 Completed H. Lee Moffitt Cancer Center and Research Institute 2007-07-31
NCT00005622 Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders https://ClinicalTrials.gov/show/NCT00005622 Completed H. Lee Moffitt Cancer Center and Research Institute 2005-09-30
NCT00004899 Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00004899 Completed Northwestern University 2004-08-31
NCT00004896 Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00004896 Completed Northwestern University 2004-08-31
NCT00004871 Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00004871 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins NA
NCT00004245 Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT00004245 Completed Memorial Sloan Kettering Cancer Center 2004-09-30
NCT00004181 Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia https://ClinicalTrials.gov/show/NCT00004181 Completed Northwestern University 2004-08-31
NCT00003961 Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00003961 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2007-12-31
NCT00003687 Treatment for Chronic Pain in Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT00003687 Completed Canadian Cancer Trials Group 2001-09-26
NCT00003593 Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00003593 Completed Children’s Oncology Group 2007-03-31
NCT00003336 Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions https://ClinicalTrials.gov/show/NCT00003336 Completed Case Comprehensive Cancer Center 2005-12-31
NCT00003335 Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer https://ClinicalTrials.gov/show/NCT00003335 Completed Case Comprehensive Cancer Center 2007-11-30
NCT00003243 Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00003243 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins NA
NCT00003116 High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00003116 Completed Case Comprehensive Cancer Center 2006-03-31
NCT00002809 Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00002809 Completed Temple University 2003-12-31
NCT00002792 Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00002792 Completed Fred Hutchinson Cancer Research Center 2003-04-30
NCT00002718 T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia https://ClinicalTrials.gov/show/NCT00002718 Completed Memorial Sloan Kettering Cancer Center 2004-01-31
NCT00038051 Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies https://ClinicalTrials.gov/show/NCT00038051 Completed M.D. Anderson Cancer Center 2013-02-28
NCT00003816 Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer https://ClinicalTrials.gov/show/NCT00003816 Completed Roswell Park Cancer Institute 2019-07-12
NCT00002746 Interleukin-2 in Treating Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00002746 Completed University of Washington 2004-04-30

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT02873832 Efficacy of Heat-shock Protein (HSP) Inhibitors in Myeloproliferative Syndromes (MPS) https://ClinicalTrials.gov/show/NCT02873832 Completed Centre Hospitalier Universitaire Dijon 2016-04-30
NCT02862366 Role of the Circulating Procoagulants Microparticles in the Hypercoagulability of MNP Ph1- https://ClinicalTrials.gov/show/NCT02862366 Completed Lille Catholic University 2016-01-25
NCT02823184 Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT02823184 Completed University Hospital, Bordeaux 2019-04-27
NCT02766153 Exploring the Mechanisms of Resistance of Stem Cells Myeloproliferative Opposite of Tyrosine Kinase Inhibitors in 3d Model Niche Endosteal https://ClinicalTrials.gov/show/NCT02766153 Recruiting Centre Hospitalier Universitaire de Nice 2020-04-30
NCT02402244 Project: Every Child for Younger Patients With Cancer https://ClinicalTrials.gov/show/NCT02402244 Recruiting Children’s Oncology Group 2020-12-14
NCT02308787 Retrospective Data Collection of Routine Use With Spectra Optia® for Platelet Depletions https://ClinicalTrials.gov/show/NCT02308787 Completed Terumo BCT 2015-05-31
NCT02269592 Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome https://ClinicalTrials.gov/show/NCT02269592 Recruiting Dana-Farber Cancer Institute 2024-12-31
NCT02252159 Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL) https://ClinicalTrials.gov/show/NCT02252159 Active, not recruiting Incyte Corporation 2019-08-31
NCT01787162 Screening for Pulmonary Vascular Changes in Patients With Chronic Myeloproliferative Diseases https://ClinicalTrials.gov/show/NCT01787162 Completed Medical University of Graz 2015-06-30
NCT01728402 Pathogenesis of Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01728402 Enrolling by invitation OHSU Knight Cancer Institute 2020-10-31
NCT01511575 Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder https://ClinicalTrials.gov/show/NCT01511575 Completed Children’s Oncology Group 2016-05-31
NCT01394640 Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients https://ClinicalTrials.gov/show/NCT01394640 Completed Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 2010-05-31
NCT04385160 Myeloproliferative Neoplasms (MPN) and COVID-19 https://ClinicalTrials.gov/show/NCT04385160 Recruiting Fondazione per la Ricerca Ospedale Maggiore 2020-07-15
NCT04192916 Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT04192916 Recruiting Fondazione per la Ricerca Ospedale Maggiore 2020-03-31
NCT04177576 Evaluation of New Biomarkers of Thrombosis in Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT04177576 Recruiting University Hospital, Bordeaux 2021-02-28
NCT04153305 European Registry for Myeloproliferative Neoplasms (MPNs) - Update of ERNEST Study https://ClinicalTrials.gov/show/NCT04153305 Recruiting Fondazione per la Ricerca Ospedale Maggiore 2021-05-31
NCT04060485 Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results https://ClinicalTrials.gov/show/NCT04060485 Recruiting National Taiwan University Hospital 2024-08-31
NCT04018209 Aquagenic Pruritus in Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT04018209 Recruiting University Hospital, Brest 2020-01-09
NCT03907774 MPN Podcast Pilot Study https://ClinicalTrials.gov/show/NCT03907774 Completed Arizona State University 2019-11-24
NCT03745378 Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study) https://ClinicalTrials.gov/show/NCT03745378 Completed Fondazione per la Ricerca Ospedale Maggiore 2018-07-07
NCT01199562 Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01199562 Completed City of Hope Medical Center 2013-12-31
NCT01137825 Registry of Older Patients With Cancer https://ClinicalTrials.gov/show/NCT01137825 Active, not recruiting UNC Lineberger Comprehensive Cancer Center 2030-06-30
NCT01137643 Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT01137643 Active, not recruiting UNC Lineberger Comprehensive Cancer Center 2040-07-31
NCT01135849 B-Receptor Signaling in Cardiomyopathy https://ClinicalTrials.gov/show/NCT01135849 Completed Stanford University 2010-10-31
NCT00996047 S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers https://ClinicalTrials.gov/show/NCT00996047 Completed Southwest Oncology Group 2012-01-31
NCT00993694 Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone https://ClinicalTrials.gov/show/NCT00993694 Completed Vanderbilt University Medical Center 2009-12-31
NCT00964821 Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00964821 Completed City of Hope Medical Center 2013-05-31
NCT00919425 S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00919425 Completed Southwest Oncology Group 2012-01-31
NCT00909467 Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative Diseases https://ClinicalTrials.gov/show/NCT00909467 Completed Medical University of Graz 2011-11-30
NCT00900406 Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00900406 Completed Vanderbilt-Ingram Cancer Center 2010-03-31
NCT00873574 JAK-STAT Signalling Pathway in Familial Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00873574 Completed Assistance Publique - Hôpitaux de Paris 2011-05-31
NCT02953704 Myelofibrosis and Essential Thrombocythemia Observational Study (MOST) https://ClinicalTrials.gov/show/NCT02953704 Active, not recruiting Incyte Corporation 2022-03-31
NCT01362985 Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor https://ClinicalTrials.gov/show/NCT01362985 Completed Sanofi 2014-07-31
NCT03688490 Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT03688490 Completed University Hospital, Brest 2013-11-04
NCT02580903 Pulmonary Hypertension in Patients With Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT02580903 Recruiting Odense University Hospital 2016-02-29
NCT00687414 Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders https://ClinicalTrials.gov/show/NCT00687414 Completed Spectrum Health Hospitals 2009-12-31
NCT00666289 Familial Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00666289 Completed Icahn School of Medicine at Mount Sinai 2015-01-20
NCT00665067 Correlative Biomarker Study in Patients With Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00665067 Completed Icahn School of Medicine at Mount Sinai 2018-07-20
NCT00569842 Investigation of the Cylex® ImmuKnow® Assay https://ClinicalTrials.gov/show/NCT00569842 Completed Indiana University 2010-02-28
NCT00513175 Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia https://ClinicalTrials.gov/show/NCT00513175 Completed University of California, San Francisco NA
NCT00511537 Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders https://ClinicalTrials.gov/show/NCT00511537 Completed University of California, San Francisco 2009-06-30
NCT00433862 Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00433862 Completed National Institutes of Health Clinical Center (CC) NA
NCT00281814 Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant https://ClinicalTrials.gov/show/NCT00281814 Completed The Cleveland Clinic 2008-12-31
NCT00281801 Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation https://ClinicalTrials.gov/show/NCT00281801 Completed Case Comprehensive Cancer Center 2008-12-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02808858 Italian Network MDS Registry https://ClinicalTrials.gov/show/NCT02808858 Recruiting Fondazione Italiana Sindromi Mielodisplastiche Onlus 2016-06-30
NCT02760238 Myeloproliferative Neoplasms (MPNs) Patient Registry https://ClinicalTrials.gov/show/NCT02760238 Recruiting University Health Network, Toronto 2025-10-31
NCT02380378 Registry of Philadelphia-Negative Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT02380378 Recruiting Hospital Israelita Albert Einstein 2022-12-31
NCT04014764 Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy https://ClinicalTrials.gov/show/NCT04014764 Recruiting Notable Labs 2022-09-30
NCT03618485 Registry of Patients With MPNs in Taiwan https://ClinicalTrials.gov/show/NCT03618485 Enrolling by invitation Chang Gung Memorial Hospital 2019-12-31